Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Disposition | 2024-05-30 6:21 pm | N/A 2032-01-11 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 45,000 | $0 | 0 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:09 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | Deck Kelly Chief Financial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2024-05-06 Exercise | 2024-05-08 4:57 pm | N/A 2028-11-26 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 19,711 | $34.24 | 0 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-28 4:36 pm | N/A 2028-11-26 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 2,896 | $35.4 | 62,624 (Direct) | View |
| 2024-03-21 Exercise | 2024-03-22 4:54 pm | N/A 2028-11-26 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 3,113 | $35.09 | 57,393 (Direct) | View |
| 2024-03-22 Exercise | 2024-03-22 4:54 pm | N/A 2028-11-26 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 110 | $35 | 57,393 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:54 pm | N/A 2028-11-26 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 16,777 | $35.02 | 57,393 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:46 pm | N/A 2030-04-21 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 32,431 | $35.43 | 2,087 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 4:20 pm | N/A 2028-11-26 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 42,523 | $35.75 | 38,020 (Direct) | View |
| 2024-03-05 Exercise | 2024-03-06 4:41 pm | N/A 2032-01-11 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 10,417 | $35.72 | 47,500 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 4:41 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 53,958 | $35.4 | 47,500 (Direct) | View |
| 2024-03-04 Exercise | 2024-03-06 4:41 pm | N/A 2033-01-03 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 8,125 | $35.6 | 47,500 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-03 6:09 pm | N/A 2033-01-03 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-01-11 Option Award | 2022-01-25 4:50 pm | N/A 2032-01-11 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 4:13 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 70,000 | $0 | 70,000 (Direct) | View |
Ownership | 2020-08-18 7:27 pm | N/A 2028-11-26 | Inhibrx Inc. | INBX | Deck Kelly Chief Financial Officer | 0 | $0 | 115,061 (Direct) | View |